TrialBMJ open2015

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy.

Sudeep P Pushpakom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.